Want to see TSE:ZEN full AI Analyst Report?
Zentek (ZEN) AI Stock Analysis
Top Page
Zentek
(TSXV:ZEN)
The overall score is driven primarily by Zentek’s weak earnings quality and significant cash burn, which are only partially offset by a relatively strong, low-leverage balance sheet that supports solvency but not yet sustainable returns. Technical indicators show the share price under pressure and below key moving averages with subdued momentum, reinforcing a cautious near-term view. Valuation metrics are constrained by negative earnings and the absence of a dividend, leaving the stock mainly a high-risk, speculative exposure to long-term execution rather than a clear value opportunity.
Zentek (ZEN) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 62.30M
- Dividend Yield
- ―
- Average Volume (3M)
- 89.41K
- Price to Earnings (P/E)
- -5.5
- Beta (1Y)
- 1.68
- Revenue Growth
- -88.29%
- EPS Growth
- -13.25%
- Country
- Canada
- Employees
- 24
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Medical - Instruments & Supplies
Zentek Business Overview & Revenue Model
Company Description
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating u...
How the Company Makes Money
Zentek’s monetization is based on commercializing its materials technologies rather than operating as a traditional commodity producer. In general terms, the company can generate revenue through (1) direct sales of products derived from its materials...
Zentek Financial Statement Overview
Summary
Income statement results show a very small and declining revenue base with deeply negative gross and net margins and widening losses, indicating the business remains far from break-even and earnings quality is weak. Cash flow is materially negative, with ongoing cash burn and recent deterioration in free cash flow momentum, underscoring continued reliance on external financing. These weaknesses are partly offset by a conservatively financed balance sheet with low absolute debt and growing equity and assets, which supports solvency but has yet to translate into strong returns for shareholders.
Income Statement
18Very NegativeBalance Sheet
62PositiveCash Flow
31Negative| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.25K | 166.05K | 872.50K | 29.82K | 72.86K | 339.67K |
| Gross Profit | -5.43M | -6.29M | 192.49K | -385.06K | -780.48K | -275.04K |
| EBITDA | -10.63M | -10.30M | -9.35M | -11.08M | -13.75M | -11.27M |
| Net Income | -10.45M | -9.77M | -10.04M | -11.70M | -14.41M | -38.69M |
Balance Sheet | ||||||
| Total Assets | 30.86M | 15.09M | 18.40M | 22.59M | 33.29M | 37.98M |
| Cash, Cash Equivalents and Short-Term Investments | 16.60M | 1.30M | 121.48K | 3.52M | 10.36M | 26.68M |
| Total Debt | 1.93M | 1.91M | 680.47K | 1.24M | 1.61M | 2.23M |
| Total Liabilities | 5.60M | 5.28M | 3.65M | 2.41M | 2.90M | 3.44M |
| Stockholders Equity | 25.26M | 9.80M | 14.75M | 20.17M | 30.38M | 34.55M |
Cash Flow | ||||||
| Free Cash Flow | -5.57M | -5.77M | -6.28M | -8.37M | -15.23M | -11.97M |
| Operating Cash Flow | -5.07M | -5.07M | -6.28M | -8.05M | -12.96M | -7.99M |
| Investing Cash Flow | -1.23M | 1.67M | 358.65K | 1.88M | -2.31M | -7.25M |
| Financing Cash Flow | 20.01M | 4.58M | 2.52M | -665.47K | -1.05M | 38.82M |
Zentek Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ZEN, the sentiment is Negative. The current price of 0.52 is below the 20-day moving average (MA) of 0.61, below the 50-day MA of 0.70, and below the 200-day MA of 0.78, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 27.16 is Positive, neither overbought nor oversold. The STOCH value of 16.85 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:ZEN.
Zentek Peers Comparison
Overall Rating
TSE:MDP63Neutral- TSE:ZEN44Neutral
TSE:SONA40.5Neutral
TSE:ARCH40Underperform
TSE:BUX40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:MDP | 63Neutral | CAD 154.93M | -46.24 | -4.69% | ― | -3.16% | -345.50% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| TSE:ZEN | 44Neutral | CAD 65.84M | -5.55 | -70.73% | ― | -88.29% | -13.25% |
| TSE:SONA | 41Neutral | CAD 34.38M | -13.08 | 448.05% | ― | ― | 24.65% |
| TSE:ARCH | 40Underperform | CAD 56.38M | -19.53 | 74.79% | ― | ― | -15.53% |
| TSE:BUX | 40Underperform | CAD 50.05M | -34.81 | -250.77% | ― | -82.05% | 23.73% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:ZEN | Zentek Ltd. | 0.52 | -0.61 | -53.98% | |
| TSE:ARCH | Arch Biopartners | 0.83 | -0.19 | -18.63% | |
| TSE:BUX | BioMark Diagnostics | 0.47 | 0.13 | 38.24% | |
| TSE:MDP | Medexus Pharmaceuticals | 4.93 | 2.13 | 76.07% | |
| TSE:SONA | Sona Nanotech, Inc | 0.28 | -0.33 | -54.10% |
Zentek Corporate Events
Zentek Drops Nasdaq Listing to Focus on Core Graphene and Critical Minerals Initiatives
NeutralZentek Ltd., a Canadian developer of graphene-based and advanced material technologies, operates across clean air solutions, next-generation materials, and critical minerals, anchored by its Albany Graphite asset and platforms such as ZenGUARD™...
Zentek Reshapes Leadership to Drive ZenGUARD Commercialization and Capital Markets Reach
PositiveZentek has expanded its leadership team to accelerate commercialization of its ZenGUARD technology and deepen its reach in capital markets, reflecting a shift toward sales execution and investor engagement as regulatory hurdles for ZenGUARD in Canada...
Zentek Confirms Strong Economics in New PEA for Albany Ultra-High-Purity Graphite Project
PositiveZentek has filed a NI 43-101-compliant Preliminary Economic Assessment technical report for its Albany graphite project, confirming robust economics with an after-tax net present value of about US$3.85 billion at a 5 percent discount rate and a 27.4...
Zentek Secures Pre-Qualification in Canada’s Defence Drone Marketplace
PositiveZentek Ltd. has been pre-qualified under the Government of Canada’s Defence Drone Initiative Marketplace, securing a five-year supply arrangement with the Defence Investment Agency running to July 31, 2031. The qualification allows Zentek to co...
Zentek Shifts U.S. Trading to OTCQX as Nasdaq Listing Suspended
NeutralZentek Ltd., a Canadian IP development and commercialization firm, specializes in graphene-enabled and advanced material technologies serving clean air applications, next-generation materials, and critical minerals markets. The company’s primar...
Zentek Clarifies OTC Debut Date and Outlines U.S. Trading Transition
NeutralZentek Ltd. corrected a previous disclosure on its U.S. trading plans, clarifying that its common shares are expected to begin quotation on the OTC Markets at the open of trading on Wednesday, September 2, 2026, rather than on a Tuesday as earlier st...
Zentek Shares to Shift From Nasdaq to OTC Markets After Delisting Notice
NegativeZentek Ltd. said its common shares will move from the Nasdaq Capital Market to the OTC Markets Group on September 2, 2026, after receiving a delisting notice tied to non-compliance with Nasdaq’s minimum bid price requirement. Trading on Nasdaq...
Zentek Wins Ottawa HVAC Filter Deal as ZenGUARD Gains Federal Traction
PositiveZentek Ltd., a Canadian IP development company, is commercializing graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals, anchored by its Albany graphite, ZenGUARD™, and Triera pl...
Zentek Files Patent for Albany-Graphite EMI Shielding Coating
PositiveZentek has filed a provisional U.S. patent application for ZEN-EMI-01, a water-based electromagnetic interference shielding coating derived from purified graphite from its Albany deposit. The coating is designed to absorb electromagnetic energy as he...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 06, 2026